Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen

E. Van Cutsem, J. Tabernero, R. Lakomy, H. Prenen, J. Prausová, T. Macarulla, P. Ruff, Guy Van Hazel, V. Moiseyenko, D. Ferry, J. Mckendrick, J. Polikoff, A. Tellier, R. Castan, C. Allegra

    Research output: Contribution to journalArticle

    762 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)3499-3506
    JournalJournal of Clinical Oncology
    Volume30
    DOIs
    Publication statusPublished - 2012

    Cite this

    Van Cutsem, E. ; Tabernero, J. ; Lakomy, R. ; Prenen, H. ; Prausová, J. ; Macarulla, T. ; Ruff, P. ; Van Hazel, Guy ; Moiseyenko, V. ; Ferry, D. ; Mckendrick, J. ; Polikoff, J. ; Tellier, A. ; Castan, R. ; Allegra, C. / Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen. In: Journal of Clinical Oncology. 2012 ; Vol. 30. pp. 3499-3506.
    @article{3ac4fb03c3584e2e8995f2c943c487a9,
    title = "Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen",
    author = "{Van Cutsem}, E. and J. Tabernero and R. Lakomy and H. Prenen and J. Prausov{\'a} and T. Macarulla and P. Ruff and {Van Hazel}, Guy and V. Moiseyenko and D. Ferry and J. Mckendrick and J. Polikoff and A. Tellier and R. Castan and C. Allegra",
    year = "2012",
    doi = "10.1200/JCO.2012.42.8201",
    language = "English",
    volume = "30",
    pages = "3499--3506",
    journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",
    issn = "0732-183X",
    publisher = "American Society of Clinical Oncology",

    }

    Van Cutsem, E, Tabernero, J, Lakomy, R, Prenen, H, Prausová, J, Macarulla, T, Ruff, P, Van Hazel, G, Moiseyenko, V, Ferry, D, Mckendrick, J, Polikoff, J, Tellier, A, Castan, R & Allegra, C 2012, 'Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen' Journal of Clinical Oncology, vol. 30, pp. 3499-3506. https://doi.org/10.1200/JCO.2012.42.8201

    Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen. / Van Cutsem, E.; Tabernero, J.; Lakomy, R.; Prenen, H.; Prausová, J.; Macarulla, T.; Ruff, P.; Van Hazel, Guy; Moiseyenko, V.; Ferry, D.; Mckendrick, J.; Polikoff, J.; Tellier, A.; Castan, R.; Allegra, C.

    In: Journal of Clinical Oncology, Vol. 30, 2012, p. 3499-3506.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen

    AU - Van Cutsem, E.

    AU - Tabernero, J.

    AU - Lakomy, R.

    AU - Prenen, H.

    AU - Prausová, J.

    AU - Macarulla, T.

    AU - Ruff, P.

    AU - Van Hazel, Guy

    AU - Moiseyenko, V.

    AU - Ferry, D.

    AU - Mckendrick, J.

    AU - Polikoff, J.

    AU - Tellier, A.

    AU - Castan, R.

    AU - Allegra, C.

    PY - 2012

    Y1 - 2012

    U2 - 10.1200/JCO.2012.42.8201

    DO - 10.1200/JCO.2012.42.8201

    M3 - Article

    VL - 30

    SP - 3499

    EP - 3506

    JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

    JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

    SN - 0732-183X

    ER -